HEADER AMINO-ACID TRANSPORT 12-FEB-79 8TNA OBSLTE 14-JUL-86 8TNA 1TRA TITLE CRYSTAL AND MOLECULAR STRUCTURE OF YEAST PHENYLALANYL TITLE 2 TRANSFER /RNA$. STRUCTURE DETERMINATION, DIFFERENCE TITLE 3 FOURIER REFINEMENT, MOLECULAR CONFORMATION, METAL AND TITLE 4 SOLVENT BINDING COMPND MOL_ID: 1; COMPND 2 MOLECULE: T-RNA (76-MER); COMPND 3 CHAIN: NULL; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS T-RNA EXPDTA X-RAY DIFFRACTION AUTHOR M.SUNDARALINGAM AND CO-WORKERS REVDAT 7 14-JUL-86 8TNA 3 OBSLTE REVDAT 6 31-JAN-84 8TNA 1 REMARK REVDAT 5 30-SEP-83 8TNA 1 REVDAT REVDAT 4 15-SEP-81 8TNA 1 REMARK REVDAT 3 31-DEC-80 8TNA 1 REMARK REVDAT 2 01-OCT-80 8TNA 1 JRNL REVDAT 1 14-MAR-79 8TNA 0 SPRSDE 14-MAR-79 8TNA 7TNA JRNL AUTH C.D.STOUT,H.MIZUNO,S.T.RAO,P.SWAMINATHAN,J.RUBIN, JRNL AUTH 2 T.BRENNAN,M.SUNDARALINGAM JRNL TITL CRYSTAL AND MOLECULAR STRUCTURE OF YEAST JRNL TITL 2 PHENYLALANYL TRANSFER /RNA. STRUCTURE JRNL TITL 3 DETERMINATION, DIFFERENCE FOURIER REFINEMENT, JRNL TITL 4 MOLECULAR CONFORMATION, METAL AND SOLVENT BINDING JRNL REF ACTA CRYSTALLOGR.,SECT.B V. 34 1529 1978 JRNL REFN ASTM ACBCAR DK ISSN 0567-7408 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.D.STOUT,H.MIZUNO,J.RUBIN,T.BRENNAN,S.T.RAO, REMARK 1 AUTH 2 M.SUNDARALINGAM REMARK 1 TITL ATOMIC COORDINATES AND MOLECULAR CONFORMATION OF REMARK 1 TITL 2 YEAST PHENYLALANYL T/RNA,AN INDEPENDENT REMARK 1 TITL 3 INVESTIGATION REMARK 1 REF NUCLEIC ACIDS RES. V. 3 1111 1976 REMARK 1 REFN ASTM NARHAD UK ISSN 0305-1048 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.SUNDARALINGAM,H.MIZUNO,C.D.STOUT,S.T.RAO, REMARK 1 AUTH 2 M.LIEBMAN,N.YATHINDRA REMARK 1 TITL MECHANISMS OF CHAIN FOLDING IN NUCLEIC ACIDS, THE REMARK 1 TITL 2 (OMEGA,OMEGA) PLOT AND ITS CORRELATION TO THE REMARK 1 TITL 3 NUCLEOTIDE GEOMETRY IN YEAST T/RNA(PHE) REMARK 1 REF NUCLEIC ACIDS RES. V. 3 2471 1976 REMARK 1 REFN ASTM NARHAD UK ISSN 0305-1048 REMARK 1 REFERENCE 3 REMARK 1 AUTH T.ICHIKAWA,M.SUNDARALINGAM REMARK 1 TITL X-RAY DIFFRACTION STUDY OF A NEW CRYSTAL FORM OF REMARK 1 TITL 2 YEAST PHENYLALANINE T/RNA REMARK 1 REF NATURE NEW BIOL. V. 236 174 1972 REMARK 1 REFN ASTM NNBYA7 UK ISSN 0369-4887 REMARK 1 REFERENCE 4 REMARK 1 EDIT M.O.DAYHOFF REMARK 1 REF ATLAS OF PROTEIN SEQUENCE V. 5 347 1972 REMARK 1 REF 2 AND STRUCTURE (DATA SECTION) REMARK 1 PUBL NATIONAL BIOMEDICAL RESEARCH FOUNDATION, SILVER REMARK 1 PUBL 2 SPRING,MD. REMARK 1 REFN ISBN 0-912466-02-2 REMARK 2 REMARK 2 RESOLUTION. NULL ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 0 REMARK 3 NUCLEIC ACID ATOMS : 1652 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8TNA COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 8TNA THE MODIFIED PURINE (Y-BASE) IN THIS TRNA IS COMMONLY REMARK 5 8TNA CALLED *WYBUTOSINE*. THE SYSTEMATIC NAME FOR THE BASE REMARK 5 PART 8TNA OF THIS NUCLEOTIDE IS 1H-IMIDAZO(1,2-ALPHA)PURINE REMARK 5 -7- 8TNA BUTANOIC ACID,4,9-DIHYDRO-ALPHA-((METHOXYCARBONYL) REMARK 5 AMINO)- 8TNA 4,6-DIMETHYL-9-OXO-METHYL ESTER. IN REALITY REMARK 5 THE PRECEEDING 8TNA IS A HIGHLY MODIFIED GUANOSINE. IT IS REMARK 5 LINKED TO THE RIBOSE 8TNA VIA THE STANDARD N9-C1* BOND. 8TNA REMARK 6 REMARK 6 8TNA THE DATA BANK HAS ADOPTED THE SACCHARIDE CHEMIST*S REMARK 6 8TNA NOMENCLATURE FOR ATOMS OF THE RIBOSE MOIETY RATHER REMARK 6 THAN 8TNA THAT OF THE NUCLEOSIDE CHEMIST. THE RING-OXYGEN REMARK 6 ATOM 8TNA ACCORDINGLY IS LABELLED O4* AND NOT O1*. 8TNA REMARK 7 REMARK 7 8TNA THE MAJOR DIFFERENCE IN THE STRUCTURE GIVEN BY THIS REMARK 7 8TNA COORDINATE SET AND THAT FROM THE MODEL OF THE REMARK 7 RESTRAINED 8TNA LEAST-SQUARES REFINEMENT LIES IN THE REGION REMARK 7 AROUND THE 8TNA RESIDUE G 20. 8TNA REMARK 8 REMARK 8 8TNA CORRECTION. CHANGE ISSN CODE FOR JRNL REFERENCE. 8TNA REMARK 8 01-OCT-80. 8TNA REMARK 9 REMARK 9 8TNA CORRECTION. STANDARDIZE FORMAT OF REMARKS 2 AND 3. REMARK 9 8TNA 31-DEC-80. 8TNA REMARK 10 REMARK 10 8TNA CORRECTION. CORRECT JOURNAL NAME FOR REFERENCE 3. 8TNA REMARK 10 15-SEP-81. 8TNA REMARK 11 REMARK 11 8TNA CORRECTION. INSERT REVDAT RECORDS. 30-SEP-83. 8TNA REMARK 12 REMARK 12 8TNA CORRECTION. CORRECT JOURNAL NAME FOR REFERENCES 1 AND REMARK 12 2. 8TNA CORRECT ISSN FOR REFERENCE 3. 31-JAN-84. 8TNA REMARK 13 REMARK 13 8TNA CORRECTION. THIS ENTRY IS OBSOLETE. 14-JUL-86. 8TNA REMARK 105 REMARK 105 THE PROTEIN DATA BANK HAS ADOPTED THE SACCHARIDE CHEMISTS REMARK 105 NOMENCLATURE FOR ATOMS OF THE DEOXYRIBOSE/RIBOSE MOIETY REMARK 105 RATHER THAN THAT OF THE NUCLEOSIDE CHEMISTS. THE RING REMARK 105 OXYGEN ATOM IS LABELLED O4* INSTEAD OF O1*. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,1/2+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 16.65000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 A 23 N6 REMARK 470 OMC 32 CM2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 O2 H2U 17 C5* C 61 1.12 REMARK 500 O4 5MU 54 N7 1MA 58 1.59 REMARK 500 C4 U 68 O4 U 69 1.60 REMARK 500 O2* H2U 17 O2 C 60 1.63 REMARK 500 O2* A 21 O2P G 22 1.69 REMARK 500 O4 U 68 O4 U 69 1.70 REMARK 500 O2* C 63 O5* A 64 1.71 REMARK 500 O2* G 71 C5* C 72 1.74 REMARK 500 O2* U 12 C5* C 13 1.83 REMARK 500 C4 2MG 10 C5 C 11 1.90 REMARK 500 O2* A 67 C6 U 68 1.92 REMARK 500 O2* G 71 C4* C 72 1.92 REMARK 500 O2* C 63 C5* A 64 1.93 REMARK 500 O2* U 7 O1P U 8 1.95 REMARK 500 C2 H2U 17 C5* C 61 1.99 REMARK 500 C4 U 68 C4 U 69 1.99 REMARK 500 O2* U 68 C5* U 69 2.03 REMARK 500 C5* G 45 O2P 7MG 46 2.05 REMARK 500 C5 U 68 O4 U 69 2.08 REMARK 500 O2* G 71 O4* C 72 2.09 REMARK 500 C6 2MG 10 N4 C 11 2.10 REMARK 500 N3 G 43 C8 A 44 2.11 REMARK 500 C2* G 71 O4* C 72 2.14 REMARK 500 C4 C 25 C8 M2G 26 2.15 REMARK 500 C2* C 63 O5* A 64 2.15 REMARK 500 C5 H2U 16 O1P G 18 2.16 REMARK 500 N3 U 68 C4 U 69 2.16 REMARK 500 C5 2MG 10 N4 C 11 2.18 REMARK 500 N4 5MC 40 O4 U 41 2.18 REMARK 500 N6 A 66 N6 A 67 2.18 REMARK 500 N1 A 29 O6 G 30 2.19 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 C2 OMG 34 C4* C 63 1544 1.58 REMARK 500 N3 OMG 34 C4* C 63 1544 1.73 REMARK 500 N2 YG 37 O2* C 75 2646 1.87 REMARK 500 C2 OMG 34 C5* C 63 1544 1.88 REMARK 500 N2 OMG 34 C4* C 63 1544 1.91 REMARK 500 N3 OMG 34 C5* C 63 1544 1.98 REMARK 500 N1 OMG 34 C5* C 63 1544 1.99 REMARK 500 C4 OMG 34 C5* C 63 1544 2.06 REMARK 500 N3 OMG 34 O4* C 63 1544 2.07 REMARK 500 C11 YG 37 O2* C 75 2646 2.14 REMARK 500 N2 OMG 34 O3* C 63 1544 2.19 SEQRES 1 76 G C G G A U U U A 2MG C U C SEQRES 2 76 A G H2U H2U G G G A G A G C M2G SEQRES 3 76 C C A G A OMC U OMG A A YG A PSU SEQRES 4 76 5MC U G G A G 7MG U C 5MC U G U SEQRES 5 76 G 5MU PSU C G 1MA U C C A C A G SEQRES 6 76 A A U U C G C A C C A MODRES 8TNA 2MG 10 G 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE MODRES 8TNA H2U 16 U 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE MODRES 8TNA H2U 17 U 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE MODRES 8TNA M2G 26 G N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE MODRES 8TNA OMC 32 C O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE MODRES 8TNA OMG 34 G O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE MODRES 8TNA YG 37 G WYBUTOSINE MODRES 8TNA PSU 39 U PSEUDOURIDINE-5'-MONOPHOSPHATE MODRES 8TNA 5MC 40 C 5-METHYLCYTIDINE-5'-MONOPHOSPHATE MODRES 8TNA 7MG 46 G MODRES 8TNA 5MC 49 C 5-METHYLCYTIDINE-5'-MONOPHOSPHATE MODRES 8TNA 5MU 54 U 5-METHYLURIDINE 5'-MONOPHOSPHATE MODRES 8TNA PSU 55 U PSEUDOURIDINE-5'-MONOPHOSPHATE MODRES 8TNA 1MA 58 A HET 2MG 10 24 HET H2U 16 20 HET H2U 17 20 HET M2G 26 25 HET OMC 32 21 HET OMG 34 24 HET YG 37 39 HET PSU 39 20 HET 5MC 40 21 HET 7MG 46 24 HET 5MC 49 21 HET 5MU 54 21 HET PSU 55 20 HET 1MA 58 23 HETNAM 2MG 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE HETNAM H2U 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE HETNAM M2G N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE HETNAM OMC O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE HETNAM OMG O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE HETNAM YG WYBUTOSINE HETNAM PSU PSEUDOURIDINE-5'-MONOPHOSPHATE HETNAM 5MC 5-METHYLCYTIDINE-5'-MONOPHOSPHATE HETNAM 7MG 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE HETNAM 5MU 5-METHYLURIDINE 5'-MONOPHOSPHATE HETNAM 1MA 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE HETSYN YG Y-BASE; 1H-IMIDAZO(1,2-ALPHA)PURINE-7-BUTANOIC ACID,4, HETSYN 2 YG 9-DIHYDRO-ALPHA-((METHOXYCARBONYL)AMINO)-4,6-DIMETHYL- HETSYN 3 YG 9-OXO-METHYL ESTER FORMUL 1 2MG C11 H16 N5 O8 P FORMUL 1 H2U 2(C9 H15 N2 O9 P) FORMUL 1 M2G C12 H18 N5 O8 P FORMUL 1 OMC C10 H16 N3 O8 P FORMUL 1 OMG C11 H16 N5 O8 P FORMUL 1 YG C21 H29 N6 O12 P FORMUL 1 PSU 2(C9 H13 N2 O9 P) FORMUL 1 5MC 2(C10 H16 N3 O8 P) FORMUL 1 7MG C11 H18 N5 O8 P FORMUL 1 5MU C10 H15 N2 O9 P FORMUL 1 1MA C11 H18 N5 O7 P CRYST1 56.000 33.300 63.000 90.00 90.40 90.00 P 1 21 1 2 ORIGX1 0.017857 0.000000 0.000125 0.00000 ORIGX2 0.000000 0.030030 0.000000 0.00000 ORIGX3 0.000000 0.000000 0.015873 0.00000 SCALE1 0.017857 0.000000 0.000125 0.00000 SCALE2 0.000000 0.030030 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015873 0.00000